Revolutionizing Eye Care: Innovative Approaches for a Brighter Vision Future

Kruti Naik from Wits University is developing cutting-edge microneedle and nanomedicine technologies to improve eye infection treatment, offering safer, more effective solutions to prevent blindness globally.
In a significant leap forward for ocular health, researcher Kruti Naik from Wits University is pioneering novel treatment methods that could transform how eye infections and diseases are managed. Traditionally, eye drops are the primary treatment for many eye conditions, but Naik is exploring more efficient, affordable alternatives using cutting-edge nanomedicine and microneedle technologies.
With a substantial portion of the global population, especially in Africa, facing blindness—due to untreated communicable infections like HIV-related conditions and non-communicable diseases such as diabetes and hypertension—these advancements are crucial. Naik’s research envisions tiny, contact lens-like patches embedded with micro-scale needles that can deliver medication painlessly directly to the front part of the eye. This approach minimizes medication waste, eliminates the need for refrigeration—a major challenge in resource-limited settings—and ensures targeted, sustained drug delivery.
The potential of microneedles extends beyond drug delivery; they can be integrated with nanomedicine to develop smart, biodegradable, and biocompatible systems capable of treating a range of eye conditions, including infections, degenerative diseases, and inflammatory disorders. Naik emphasizes that this technology could be life-changing, particularly by providing prompt and effective treatment that prevents blindness.
Currently collaborating with experts at Queen's University Belfast, Naik is working on peptide-based hydrogels that can self-assemble to fight infections and act as long-lasting implants for steady medication release. Her work, supported by the Wits Foundation UK and supervised by prominent professors, highlights how innovative biomedical engineering can make treatments less invasive and more accessible.
Naik’s broader vision is to adapt this technology to other diseases, including cancer, demonstrating the versatility of her approach. Her prior studies show that these hydrogels are safe, stable, and capable of reducing multiple invasive procedures by acting as sustained drug depots within the eye.
As a female scientist leading impactful research, Naik’s work embodies the vital role of women in advancing medical science. Her focus on patient-centric and accessible healthcare solutions underscores the importance of developing treatments that are effective in real-world settings, especially for vulnerable populations such as women and children in Africa.
This innovative research underscores a future where eye care is more precise, less invasive, and globally accessible, potentially saving countless individuals from vision loss.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
PFAS Detected in the Blood of Children in Northern Spain
A study in northern Spain confirms the presence of PFAS chemicals in children's blood, highlighting the need for ongoing monitoring and stronger regulations to safeguard health amidst widespread environmental contamination.
Chiropractic Therapy Linked to Lower Risk of Opioid Use Disorder in Low Back Pain Patients
A new study shows that chiropractic spinal manipulative therapy significantly reduces the risk of developing opioid use disorder in low back pain patients, offering a promising nonpharmacological treatment option amidst the opioid crisis.
TMEM63A Gene and Its Role in Brain Myelin Formation in Leukodystrophy
Researchers at Oregon Health & Science University have identified the TMEM63A gene as a key regulator of myelin formation in the brain, offering new insights into rare leukodystrophies and potential treatments for demyelinating diseases like multiple sclerosis.



